Proposed Settlement to Make $63.8 Million Available for Individuals Who Purchased Paxil(R) or Paxil CR(TM) for Minors

[Guest guest]

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104 & STORY=/www/story/12-21-200\

6/0004495546 & EDATE=

Proposed Settlement to Make $63.8 Million Available for Individuals Who

Purchased Paxil® or Paxil CR for Minors EDWARDSVILLE, Ill., Dec. 21

/PRNewswire-USNewswire/ -- All persons in

the United States who purchased Paxil® or Paxil CR prescribed for

consumption by a minor child may be eligible for relief as part of a $63.8

million Proposed Settlement. The lawsuit alleges that GlaxoKline

( " GSK " ) promoted Paxil® or Paxil CR for prescription to children and

adolescents while withholding and concealing material information about the

medication's safety and effectiveness for minors. GSK denies all claims.

Paxil® is a drug used to treat depression and anxiety disorders. It

belongs to the family of drugs called selective serotonin reuptake

inhibitors (SSRI). Paxil® is also called paroxetine hydrochloride.

If approved, the Proposed Settlement will provide $63.8 million to pay

consumers, who submit valid Claim Forms, cash for the total amount they

paid for Paxil® or Paxil CR. Eligible Class Members can get up to

100% of the amount paid for Paxil® or Paxil CR.

" I encourage all individuals who purchased Paxil® or Paxil CR for

minors to visit the Web site or call the toll-free number to learn more

about their legal rights and filing a claim, " explained Class Counsel

M. Tillery of Korein Tillery in St. Louis, MO.

Potential Class Members do not need to do anything to stay in the

class, however, they must submit a Claim Form if they wish to obtain money

from the Settlement. Claim Forms are available by visiting the Web site

http://www.PaxilPediatricSettlement.com or by calling 1-866-494-8404. Claim

Forms must be signed and received by August 31, 2007.

Class Members wishing to exclude themselves or to object to the

Proposed Settlement must do so as outlined in the Notice of Proposed Class

Action Settlement, available by visiting the informational Web site

http://www.PaxilPediatricSettlement.com or by calling 1-866-494-8404. Those

wishing to object or exclude themselves from the Proposed Settlement must

do so no later than February 23, 2007.

The Court will hold a Final Approval Hearing on March 9, 2007. At that

time, the Court will consider whether to approve the Proposed Settlement

and award attorneys' fees and costs. All potential Class Members are

encouraged to visit http://www.PaxilPediatricSettlement.com or call

1-866-494-8404 to determine if they are a Class Member and obtain

information about their legal rights, how to file a Claim, or how to object

or exclude themselves.

[Guest guest]

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104 & STORY=/www/story/12-21-200\

6/0004495546 & EDATE=

Proposed Settlement to Make $63.8 Million Available for Individuals Who

Purchased Paxil® or Paxil CR for Minors EDWARDSVILLE, Ill., Dec. 21

/PRNewswire-USNewswire/ -- All persons in

the United States who purchased Paxil® or Paxil CR prescribed for

consumption by a minor child may be eligible for relief as part of a $63.8

million Proposed Settlement. The lawsuit alleges that GlaxoKline

( " GSK " ) promoted Paxil® or Paxil CR for prescription to children and

adolescents while withholding and concealing material information about the

medication's safety and effectiveness for minors. GSK denies all claims.

Paxil® is a drug used to treat depression and anxiety disorders. It

belongs to the family of drugs called selective serotonin reuptake

inhibitors (SSRI). Paxil® is also called paroxetine hydrochloride.

If approved, the Proposed Settlement will provide $63.8 million to pay

consumers, who submit valid Claim Forms, cash for the total amount they

paid for Paxil® or Paxil CR. Eligible Class Members can get up to

100% of the amount paid for Paxil® or Paxil CR.

" I encourage all individuals who purchased Paxil® or Paxil CR for

minors to visit the Web site or call the toll-free number to learn more

about their legal rights and filing a claim, " explained Class Counsel

M. Tillery of Korein Tillery in St. Louis, MO.

Potential Class Members do not need to do anything to stay in the

class, however, they must submit a Claim Form if they wish to obtain money

from the Settlement. Claim Forms are available by visiting the Web site

http://www.PaxilPediatricSettlement.com or by calling 1-866-494-8404. Claim

Forms must be signed and received by August 31, 2007.

Class Members wishing to exclude themselves or to object to the

Proposed Settlement must do so as outlined in the Notice of Proposed Class

Action Settlement, available by visiting the informational Web site

http://www.PaxilPediatricSettlement.com or by calling 1-866-494-8404. Those

wishing to object or exclude themselves from the Proposed Settlement must

do so no later than February 23, 2007.

The Court will hold a Final Approval Hearing on March 9, 2007. At that

time, the Court will consider whether to approve the Proposed Settlement

and award attorneys' fees and costs. All potential Class Members are

encouraged to visit http://www.PaxilPediatricSettlement.com or call

1-866-494-8404 to determine if they are a Class Member and obtain

information about their legal rights, how to file a Claim, or how to object

or exclude themselves.

[Guest guest]

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104 & STORY=/www/story/12-21-200\

6/0004495546 & EDATE=

Proposed Settlement to Make $63.8 Million Available for Individuals Who

Purchased Paxil® or Paxil CR for Minors EDWARDSVILLE, Ill., Dec. 21

/PRNewswire-USNewswire/ -- All persons in

the United States who purchased Paxil® or Paxil CR prescribed for

consumption by a minor child may be eligible for relief as part of a $63.8

million Proposed Settlement. The lawsuit alleges that GlaxoKline

( " GSK " ) promoted Paxil® or Paxil CR for prescription to children and

adolescents while withholding and concealing material information about the

medication's safety and effectiveness for minors. GSK denies all claims.

Paxil® is a drug used to treat depression and anxiety disorders. It

belongs to the family of drugs called selective serotonin reuptake

inhibitors (SSRI). Paxil® is also called paroxetine hydrochloride.

If approved, the Proposed Settlement will provide $63.8 million to pay

consumers, who submit valid Claim Forms, cash for the total amount they

paid for Paxil® or Paxil CR. Eligible Class Members can get up to

100% of the amount paid for Paxil® or Paxil CR.

" I encourage all individuals who purchased Paxil® or Paxil CR for

minors to visit the Web site or call the toll-free number to learn more

about their legal rights and filing a claim, " explained Class Counsel

M. Tillery of Korein Tillery in St. Louis, MO.

Potential Class Members do not need to do anything to stay in the

class, however, they must submit a Claim Form if they wish to obtain money

from the Settlement. Claim Forms are available by visiting the Web site

http://www.PaxilPediatricSettlement.com or by calling 1-866-494-8404. Claim

Forms must be signed and received by August 31, 2007.

Class Members wishing to exclude themselves or to object to the

Proposed Settlement must do so as outlined in the Notice of Proposed Class

Action Settlement, available by visiting the informational Web site

http://www.PaxilPediatricSettlement.com or by calling 1-866-494-8404. Those

wishing to object or exclude themselves from the Proposed Settlement must

do so no later than February 23, 2007.

The Court will hold a Final Approval Hearing on March 9, 2007. At that

time, the Court will consider whether to approve the Proposed Settlement

and award attorneys' fees and costs. All potential Class Members are

encouraged to visit http://www.PaxilPediatricSettlement.com or call

1-866-494-8404 to determine if they are a Class Member and obtain

information about their legal rights, how to file a Claim, or how to object

or exclude themselves.

[Guest guest]

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104 & STORY=/www/story/12-21-200\

6/0004495546 & EDATE=

Proposed Settlement to Make $63.8 Million Available for Individuals Who

Purchased Paxil® or Paxil CR for Minors EDWARDSVILLE, Ill., Dec. 21

/PRNewswire-USNewswire/ -- All persons in

the United States who purchased Paxil® or Paxil CR prescribed for

consumption by a minor child may be eligible for relief as part of a $63.8

million Proposed Settlement. The lawsuit alleges that GlaxoKline

( " GSK " ) promoted Paxil® or Paxil CR for prescription to children and

adolescents while withholding and concealing material information about the

medication's safety and effectiveness for minors. GSK denies all claims.

Paxil® is a drug used to treat depression and anxiety disorders. It

belongs to the family of drugs called selective serotonin reuptake

inhibitors (SSRI). Paxil® is also called paroxetine hydrochloride.

If approved, the Proposed Settlement will provide $63.8 million to pay

consumers, who submit valid Claim Forms, cash for the total amount they

paid for Paxil® or Paxil CR. Eligible Class Members can get up to

100% of the amount paid for Paxil® or Paxil CR.

" I encourage all individuals who purchased Paxil® or Paxil CR for

minors to visit the Web site or call the toll-free number to learn more

about their legal rights and filing a claim, " explained Class Counsel

M. Tillery of Korein Tillery in St. Louis, MO.

Potential Class Members do not need to do anything to stay in the

class, however, they must submit a Claim Form if they wish to obtain money

from the Settlement. Claim Forms are available by visiting the Web site

http://www.PaxilPediatricSettlement.com or by calling 1-866-494-8404. Claim

Forms must be signed and received by August 31, 2007.

Class Members wishing to exclude themselves or to object to the

Proposed Settlement must do so as outlined in the Notice of Proposed Class

Action Settlement, available by visiting the informational Web site

http://www.PaxilPediatricSettlement.com or by calling 1-866-494-8404. Those

wishing to object or exclude themselves from the Proposed Settlement must

do so no later than February 23, 2007.

The Court will hold a Final Approval Hearing on March 9, 2007. At that

time, the Court will consider whether to approve the Proposed Settlement

and award attorneys' fees and costs. All potential Class Members are

encouraged to visit http://www.PaxilPediatricSettlement.com or call

1-866-494-8404 to determine if they are a Class Member and obtain

information about their legal rights, how to file a Claim, or how to object

or exclude themselves.